UNSPSC 51393408: Acefylline

This classification denotes a bronchodilator with the molecular structure C9H10N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, M494UE2YEP chemically known as 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxopurine-7-acetic a but generally known as acefylline, which bears US NIH Compound Identifier 69550. European Medicines Agency schedules Acefylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00243MIG.

The term ACEFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, no. 5 1981, list 21). As of Q4 2014, ACEFYLLINE remains the US FDA Preferred Term for this commodity. Acefylline bears US NLM identifiers UMLS ID C0050405 and NCI Concept Code C96200. SMILES: CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(=O)O.

UNSPSC 51393408 Acefylline is a Commodity code that maps to pharmaceutical and medical supply procurement, though the recent state and local opportunities tagged under it diverge significantly from the code's nominal scope. Seminole County, Florida issued IFB60459723LAS in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for community health initiatives, with quarterly deliveries and a two-year initial term plus one-year renewal option. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, exploring direct contracting relationships between state pharmacy benefit programs and pharmaceutical manufacturers outside traditional pharmacy benefit manager and group purchasing organization channels. Neither opportunity aligns closely with acefylline (a bronchodilator medication) as a discrete procurement line item; the code appears to capture pharmaceutical procurement broadly rather than a specific active ingredient or drug class.

Issuing bodies include county health departments and state health and human services agencies. Geographically, the recent opportunities span Florida and Texas. The Seminole County solicitation is a competitive IFB due July 26, 2023 (note: the source dates appear inconsistent, with posting in June 2026 against a 2023 response deadline), requiring electronic bid submission through the county e-Procurement Portal, unit pricing for each line item, E-Verify compliance, and workers' compensation and commercial general liability insurance. The Texas RFI, posted April 3, 2026 with immediate response deadline, serves as a preliminary market-intelligence phase preceding a formal RFP and does not establish award values, budget ranges, or binding timelines. The code shows limited recent activity directly aligned to acefylline procurement; the tagged opportunities represent broader pharmaceutical and medical supply sourcing rather than procurement of this specific therapeutic agent.